ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
India–US Trade Pact 2026: A New Highway to a USD 500 Billion Partnership